Picard Medical, Inc. PMI
Analyst Ratings
- Consensus
- Hold — 0 Buy · 1 Hold · 0 Sell (1 analysts)
- Avg. Price Target
- —
Key Stats
- Today's Range
- $5.84 – $11.13
- 50-Day Range
- $2.65 – $17.84
- 52-Week Range
- $2.65 – $684.00
- Volume
- 41.57 million shs
- Average Volume
- 3.05 million shs
- Market Cap
- $10.54 million
- P/E Ratio
- —
- Dividend Yield
- 0.10%
Valuation
- P/E Ratio
- —
- Price / Book
- 6.14
- Price / Sales
- 1.67
Dividend
- Dividend Yield
- 0.10%
- Annual Dividend
- $0.01
- Payout Ratio
- —
- Ex-Dividend Date
- 2008-12-29
Short Interest
- Short Interest
- 2.23%
- Days to Cover
- 1.00
Financials (TTM)
- Revenue
- $6.30 million
- Net Income
- $-27,993,000
- Net Margin
- -444.33%
- Return on Equity
- -1631.29%
- Debt-to-Equity
- —
About Picard Medical, Inc.
Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing the SynCardia TAH, an implantable total artificial heart system. The company is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including the SynCardia TAH, which is designed to assume the full function of a failed human heart in patients suffering from advanced heart failure. The SynCardia TAH replaces both the left and right ventricles as well as all four heart valves.
Related Stocks
Compare head-to-head: PMI vs SYK·PMI vs BSX·PMI vs RMD·PMI vs BAX
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.